Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kopran Limited ( (IN:KOPRAN) ) has provided an update.
Kopran Limited has announced that its trading window for dealing in the company’s securities will be closed for directors, designated persons and their immediate relatives from 1 January 2026 until 48 hours after the announcement of its unaudited financial results for the third quarter ended 31 December 2025, in line with SEBI’s Prohibition of Insider Trading Regulations and the company’s internal code for handling unpublished price-sensitive information. The board meeting date to consider and approve these Q3 FY2025-26 results will be communicated later, and the move underscores the company’s adherence to regulatory norms aimed at safeguarding market integrity and preventing insider trading during sensitive financial disclosure periods.
More about Kopran Limited
Kopran Limited is an India-based pharmaceutical company headquartered in Mumbai, engaged in the manufacture and sale of pharmaceutical formulations and active pharmaceutical ingredients, serving domestic and international healthcare markets.
Average Trading Volume: 14,144
Technical Sentiment Signal: Sell
Current Market Cap: 6.28B INR
Find detailed analytics on KOPRAN stock on TipRanks’ Stock Analysis page.